Colon cancer metastasis blocked by curcumin
the ONA take:
According to new research published in the journal PLOS One, curcumin, a bioactive molecule derived from tumeric, can prevent colon cancer metastasis. Researchers from the University of Arizona's Steele Children's Research Center in Tucson, Arizona, curcumin inhibits cortacin, a protein necessary for cell movement, in colon cancer. Because cortacin is often overexpressed in cancer cells, it provides cancer cells with the ability to move and metastasize to other parts of the body.
The researchers discovered the active part of cortacin, Phospho Tyrosine 421 (pTyr421) to be overexpressed in malignant colon cancer cells. The malignant cancer cells were then treated with curcumin and found that curcumin inhibited pTyr421. Tus, the colon cancer cells lost their ability to spread and migrate.
This study lays the foundation for future studies involving curcumin to be conducted for the prevention of cancer metastasis. Eventually, drugs may be designed with curcumin to block colon cancer cells from spreading.
According to the Centers for Disease Control and Prevention (CDC), colorectal cancer is the second leading cause of cancer-related death of both men and women in the United States.
Curcumin, derived from the spice turmeric, blocks the protein cortactin in colon cancer.
Novel research led by the UA Steele Children's Research Center has identified one of the mechanisms by which curcumin, a bioactive molecule derived from the spice turmeric, can prevent cancer cell metastasis in colon cancer.
A team of researchers led by the University of Arizona's Steele Children's Research Center discovered that curcumin – the bioactive molecule derived from the spice turmeric – blocks the protein cortactin in colon cancer.
Cortactin, a protein essential for cell movement, frequently is overexpressed in cancer, thus facilitating cancer cell metastasis to other organs in the body.
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Risk of Second Cancers Increased in Hodgkin Lymphoma Survivors
- Directly Informing Patients of Breast Cancer Risk, Options Improves Follow-Up Screening
- Single Fraction of HDR Brachytherapy Found Effective in Localized Prostate Cancer
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- The Integration of Cannabis in Oncologic Care
- CTCs Promising as Biomarker to Identify Lung Cancer Recurrence
- Hypofractionated RT, Conventional RT Comparable in Intermediate-Risk Prostate Cancer
- Social Functioning Scores for Young Cancer Survivors Remain Lower Than Their Peers
- Mortality Rates Highest Among Youngest Oncology Patients, Particularly Minorities
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|